MyMD Pharmaceuticals (MYMD) Competitors $0.18 -0.02 (-10.14%) As of 05/20/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesOptions ChainSEC FilingsTrendsBuy This Stock MYMD vs. TNFA, GRTX, AKAN, ADXS, PRFX, SLRX, ONCT, IXHL, MAAQ, and BPTHShould you be buying MyMD Pharmaceuticals stock or one of its competitors? The main competitors of MyMD Pharmaceuticals include TNF Pharmaceuticals (TNFA), Galera Therapeutics (GRTX), Akanda (AKAN), Ayala Pharmaceuticals (ADXS), PainReform (PRFX), Salarius Pharmaceuticals (SLRX), Oncternal Therapeutics (ONCT), Incannex Healthcare (IXHL), Mana Capital Acquisition (MAAQ), and Bio-Path (BPTH). These companies are all part of the "pharmaceutical products" industry. MyMD Pharmaceuticals vs. TNF Pharmaceuticals Galera Therapeutics Akanda Ayala Pharmaceuticals PainReform Salarius Pharmaceuticals Oncternal Therapeutics Incannex Healthcare Mana Capital Acquisition Bio-Path TNF Pharmaceuticals (NASDAQ:TNFA) and MyMD Pharmaceuticals (NASDAQ:MYMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, community ranking, risk and institutional ownership. Which has more volatility and risk, TNFA or MYMD? TNF Pharmaceuticals has a beta of 2.13, indicating that its share price is 113% more volatile than the S&P 500. Comparatively, MyMD Pharmaceuticals has a beta of 2.15, indicating that its share price is 115% more volatile than the S&P 500. Does the media prefer TNFA or MYMD? In the previous week, TNF Pharmaceuticals had 8 more articles in the media than MyMD Pharmaceuticals. MarketBeat recorded 8 mentions for TNF Pharmaceuticals and 0 mentions for MyMD Pharmaceuticals. TNF Pharmaceuticals' average media sentiment score of 0.07 beat MyMD Pharmaceuticals' score of 0.00 indicating that TNF Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment TNF Pharmaceuticals Neutral MyMD Pharmaceuticals Neutral Does the MarketBeat Community prefer TNFA or MYMD? TNF Pharmaceuticals and MyMD Pharmaceuticals both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformTNF PharmaceuticalsN/AN/AMyMD PharmaceuticalsN/AN/A Which has higher earnings & valuation, TNFA or MYMD? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTNF PharmaceuticalsN/AN/A-$4M-$6.67-0.02MyMD PharmaceuticalsN/AN/A-$4MN/AN/A Is TNFA or MYMD more profitable? MyMD Pharmaceuticals' return on equity of -179.05% beat TNF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets TNF PharmaceuticalsN/A -180.71% -84.27% MyMD Pharmaceuticals N/A -179.05%-108.14% Do insiders & institutionals have more ownership in TNFA or MYMD? 9.6% of TNF Pharmaceuticals shares are held by institutional investors. Comparatively, 9.6% of MyMD Pharmaceuticals shares are held by institutional investors. 1.2% of TNF Pharmaceuticals shares are held by insiders. Comparatively, 2.1% of MyMD Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryTNF Pharmaceuticals and MyMD Pharmaceuticals tied by winning 3 of the 6 factors compared between the two stocks. Get MyMD Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MYMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MYMD vs. The Competition Export to ExcelMetricMyMD PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$424,000.00$2.61B$5.33B$8.43BDividend YieldN/A0.73%5.21%4.11%P/E RatioN/A7.4226.8519.75Price / SalesN/A35.23388.74118.67Price / CashN/A15.7538.2534.62Price / Book0.025.436.764.50Net Income-$4M-$65.73M$3.23B$248.32M7 Day Performance-18.78%0.57%1.71%0.48%1 Month Performance4.43%3.43%11.16%13.08%1 Year Performance-91.05%-15.88%17.17%7.36% MyMD Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MYMDMyMD PharmaceuticalsN/A$0.18-10.1%N/A-91.4%$424,000.00N/A0.006High Trading VolumeTNFATNF PharmaceuticalsN/A$0.18-8.8%N/AN/A$1.81MN/A-0.026Earnings ReportHigh Trading VolumeGRTXGalera TherapeuticsN/A$0.02+0.8%N/A-87.2%$1.80MN/A-0.0730Gap DownAKANAkandaN/A$1.22+1.7%N/A-83.3%$1.74M$836,664.000.00110Positive NewsGap UpADXSAyala PharmaceuticalsN/A$0.04flatN/A-87.5%$1.71M$3.24M-0.0120News CoverageAnalyst ForecastPRFXPainReform1.8078 of 5 stars$1.92-0.5%$8.00+316.7%-37.7%$1.68MN/A-0.014Gap DownSLRXSalarius Pharmaceuticals1.179 of 5 stars$0.78-1.6%N/A-79.1%$1.66MN/A-0.1020Positive NewsONCTOncternal Therapeutics1.253 of 5 stars$0.53flat$10.00+1,799.0%N/A$1.56M$790,000.00-0.0530News CoverageAnalyst ForecastIXHLIncannex Healthcare0.4766 of 5 stars$0.09+0.4%N/A-91.6%$1.52M$98,000.00-0.063News CoverageEarnings ReportGap DownHigh Trading VolumeMAAQMana Capital AcquisitionN/A$0.19-12.9%N/A+589.8%$1.50MN/A0.001High Trading VolumeBPTHBio-Path1.6349 of 5 stars$0.18+5.8%$20.00+11,017.3%-91.5%$1.50MN/A0.0010News CoverageAnalyst Forecast Related Companies and Tools Related Companies TNFA Alternatives GRTX Alternatives AKAN Alternatives ADXS Alternatives PRFX Alternatives SLRX Alternatives ONCT Alternatives IXHL Alternatives MAAQ Alternatives BPTH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MYMD) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyMD Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MyMD Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MYMD Stock Free MYMD Stock Alerts